PTC Therapeutics, Inc. (PTCT) /
The cash flow of PTC Therapeutics, Inc. over the past 10 years
Chart PTC Therapeutics, Inc.: operating cash flow, capital expenditures, free cash flow, fiscal 2016–2025 Open the chart →In fiscal 2025, the latest fiscal year on file, PTC Therapeutics, Inc.'s operating cash flow was $711.2M and its capital expenditures $8.86M, leaving free cash flow of $702.34M. Free cash flow was above zero in 1 of the 10 years shown. It ranged from -$388.67M in fiscal 2022 to $702.34M in fiscal 2025. Capital expenditures were highest in fiscal 2022, at $32.02M.
Year by year
| Fiscal year | Operating cash flow | Capital expenditures | Free cash flow* |
|---|---|---|---|
| 2025ended Dec 31, 2025 | $711.2M | $8.86M | $702.34M |
| 2024ended Dec 31, 2024 | -$107.69M | $6.5M | -$114.19M |
| 2023ended Dec 31, 2023 | -$158.42M | $28.44M | -$186.86M |
| 2022ended Dec 31, 2022 | -$356.65M | $32.02M | -$388.67M |
| 2021ended Dec 31, 2021 | -$251.33M | $28.21M | -$279.55M |
| 2020ended Dec 31, 2020 | -$194.07M | $17.84M | -$211.91M |
| 2019ended Dec 31, 2019 | -$98.64M | $13.76M | -$112.4M |
| 2018ended Dec 31, 2018 | -$27.64M | $7.1M | -$34.74M |
| 2017ended Dec 31, 2017 | -$10.06M | $3.1M | -$13.16M |
| 2016ended Dec 31, 2016 | -$103.57M | $1.78M | -$105.34M |
Fiscal years as PTC Therapeutics, Inc. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on PTC Therapeutics, Inc.
- The revenue of PTC Therapeutics, Inc.
- The profitability of PTC Therapeutics, Inc.
- The debt of PTC Therapeutics, Inc.
- All of PTC Therapeutics, Inc.'s financials, charted
Companies of a similar size
- BROSDutch Bros Inc.
- ABCBAMERIS BANCORP
- MMSIMERIT MEDICAL SYSTEMS INC
- RDNTRadNet, Inc.
- GXOGXO Logistics, Inc.
Not investment advice. This page shows what PTC Therapeutics, Inc. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.